SQA
NAVB
Simon Quick Advisors’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-10
| Closed | – | – | 421 |
|
|
2022
Q1 | $0 | Hold |
10
| – | – | ﹤0.01% | 371 |
|
|
2021
Q4 | $0 | Hold |
10
| – | – | ﹤0.01% | 432 |
|
|
2021
Q3 | $0 | Hold |
10
| – | – | ﹤0.01% | 457 |
|
|
2021
Q2 | $0 | Hold |
10
| – | – | ﹤0.01% | 489 |
|
|
2021
Q1 | $0 | Hold |
10
| – | – | ﹤0.01% | 485 |
|
|
2020
Q4 | $0 | Hold |
10
| – | – | ﹤0.01% | 574 |
|
|
2020
Q3 | $0 | Hold |
10
| – | – | ﹤0.01% | 528 |
|
|
2020
Q2 | $0 | Hold |
10
| – | – | ﹤0.01% | 516 |
|
|
2020
Q1 | $1K | Hold |
10
| – | – | ﹤0.01% | 473 |
|
|
2019
Q4 | $0 | Hold |
10
| – | – | ﹤0.01% | 697 |
|
|
2019
Q3 | $0 | Hold |
10
| – | – | ﹤0.01% | 572 |
|
|
2019
Q2 | $6 | Hold |
10
| – | – | ﹤0.01% | 469 |
|
|
2019
Q1 | $0 | Hold |
10
| – | – | ﹤0.01% | 462 |
|
|
2018
Q4 | $0 | Hold |
10
| – | – | ﹤0.01% | 388 |
|
|
2018
Q3 | $0 | Hold |
10
| – | – | ﹤0.01% | 356 |
|
|
2018
Q2 | $0 | Hold |
10
| – | – | ﹤0.01% | 386 |
|
|
2018
Q1 | $0 | Hold |
10
| – | – | ﹤0.01% | 453 |
|
|
2017
Q4 | $0 | Hold |
10
| – | – | ﹤0.01% | 621 |
|
|
2017
Q3 | $0 | Hold |
10
| – | – | ﹤0.01% | 548 |
|
|
2017
Q2 | $0 | Hold |
10
| – | – | ﹤0.01% | 398 |
|
|
2017
Q1 | $0 | Hold |
10
| – | – | ﹤0.01% | 400 |
|
|
2016
Q4 | $1K | Buy |
+10
| New | +$1K | ﹤0.01% | 231 |
|